Literature DB >> 34355180

Human carboxylesterases and fluorescent probes to image their activity in live cells.

Anchal Singh1, Mingze Gao2, Michael W Beck1.   

Abstract

Human carboxylesterases (CESs) are serine hydrolases that are responsible for the phase I metabolism of an assortment of ester, amide, thioester, carbonate, and carbamate containing drugs. CES activity is known to be influenced by a variety of factors including single nucleotide polymorphisms, alternative splicing, and drug-drug interactions. These different factors contribute to interindividual variability of CES activity which has been demonstrated to influence clinical outcomes among people treated with CES-substrate therapeutics. Detailed exploration of the factors that influence CES activity is emerging as an important area of research. The use of fluorescent probes with live cell imaging techniques can selectively visualize the real-time activity of CESs and have the potential to be useful tools to help reveal the impacts of CES activity variations on human health. This review summarizes the properties of the five known human CESs including factors reported to or that could potentially influence their activity before discussing the design aspects and use considerations of CES fluorescent probes in general in addition to highlighting several well-characterized probes. This journal is © The Royal Society of Chemistry.

Entities:  

Year:  2021        PMID: 34355180      PMCID: PMC8292992          DOI: 10.1039/d1md00073j

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  128 in total

1.  Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol.

Authors:  Man Tang; Madhu Mukundan; Jian Yang; Nathan Charpentier; Edward L LeCluyse; Chris Black; Dongfang Yang; Deshi Shi; Bingfang Yan
Journal:  J Pharmacol Exp Ther       Date:  2006-08-30       Impact factor: 4.030

2.  Crystal structures of human carboxylesterase 1 in covalent complexes with the chemical warfare agents soman and tabun.

Authors:  Christopher D Fleming; Carol C Edwards; Stephen D Kirby; Donald M Maxwell; Philip M Potter; Douglas M Cerasoli; Matthew R Redinbo
Journal:  Biochemistry       Date:  2007-04-04       Impact factor: 3.162

3.  Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil.

Authors:  Nobuhiro Fujiyama; Masatomo Miura; Shoutaro Kato; Tomomichi Sone; Masakazu Isobe; Shigeru Satoh
Journal:  Drug Metab Dispos       Date:  2010-09-07       Impact factor: 3.922

4.  Human carboxylesterases HCE1 and HCE2: ontogenic expression, inter-individual variability and differential hydrolysis of oseltamivir, aspirin, deltamethrin and permethrin.

Authors:  Dongfang Yang; Robin E Pearce; Xiliang Wang; Roger Gaedigk; Yu-Jui Yvonne Wan; Bingfang Yan
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

Review 5.  Human carboxylesterases: an update on CES1, CES2 and CES3.

Authors:  Sonal P Sanghani; Paresh C Sanghani; Marissa A Schiel; William F Bosron
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

6.  In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors.

Authors:  Ragnar Thomsen; Henrik B Rasmussen; Kristian Linnet
Journal:  Drug Metab Dispos       Date:  2013-10-18       Impact factor: 3.922

7.  Endoplasmic Reticulum Targeting Ratiometric Fluorescent Probe for Carboxylesterase 2 Detection in Drug-Induced Acute Liver Injury.

Authors:  Xiangge Tian; Fei Yan; Jingyuan Zheng; Xiaolin Cui; Lei Feng; Sheng Li; Lingling Jin; Tony D James; Xiaochi Ma
Journal:  Anal Chem       Date:  2019-11-25       Impact factor: 6.986

8.  Different hydrolases involved in bioactivation of prodrug-type angiotensin receptor blockers: carboxymethylenebutenolidase and carboxylesterase 1.

Authors:  Tomoko Ishizuka; Yasushi Yoshigae; Nobuyuki Murayama; Takashi Izumi
Journal:  Drug Metab Dispos       Date:  2013-08-14       Impact factor: 3.922

9.  Active Site Hydrophobicity and the Convergent Evolution of Paraoxonase Activity in Structurally Divergent Enzymes: The Case of Serum Paraoxonase 1.

Authors:  David Blaha-Nelson; Dennis M Krüger; Klaudia Szeler; Moshe Ben-David; Shina Caroline Lynn Kamerlin
Journal:  J Am Chem Soc       Date:  2017-01-11       Impact factor: 15.419

10.  A molecular specificity code for the three mammalian KDEL receptors.

Authors:  Irina Raykhel; Heli Alanen; Kirsi Salo; Jaana Jurvansuu; Van Dat Nguyen; Maria Latva-Ranta; Lloyd Ruddock
Journal:  J Cell Biol       Date:  2007-12-17       Impact factor: 10.539

View more
  1 in total

1.  Assessing and utilizing esterase specificity in antimicrobial prodrug development.

Authors:  Kenton J Hetrick; Ronald T Raines
Journal:  Methods Enzymol       Date:  2021-12-23       Impact factor: 1.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.